Global Avanafil Market by Medication Type (Erectile dysfunction, and Pulmonary hypertension), Product (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, Vitaros and Others), Route of Administration (Oral drugs and Injection), Distribution Channel (Offline & Online) and Dosage (25mg, 50mg, 100mg & 200mg) - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022-2030

Table Of Contents

Chapter 1. Executive Summary

Chapter 2. Research Methodology

2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook

3.1. Introduction
3.2. Key trends
3.2.1. Increasing Adoption of Alcohol and Tobacco is Expected to Drive the Market Growth
3.3. Market drivers
3.3.1. Increasing Awareness Associated with ED Drugs Augmenting the Market Growth   
3.4. Market restraints
3.4.1. Concerns Pertaining to Consumption of Avanafil leading to Side Effects Hampering the Market Growth 
3.5. Market opportunities
3.5.1. Increasing Distribution Channel Across Rural Population
3.6. Market Challenges
3.6.1. Concerns Pertaining to Recalling of Products
3.7. Porter's Five Forces analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis

Chapter 4. COVID-19 Impact On Avanafil Market

Chapter 5. Global Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)

5.1. Global Avanafil Market Share, By Medication Type, 2017 - 2030 (USD Million)
5.1.1. Erectile dysfunction
5.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
5.1.2. Pulmonary hypertension 
5.1.2.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)

Chapter 6. Global Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)

6.1. Global Avanafil Market Share, By Product, 2017 - 2030 (USD Million)
6.1.1. Viagra
6.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.2. Cialis
6.1.2.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.3. Levitra/Staxyn
6.1.3.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.4. Stendra/Spedra
6.1.4.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.5. Zydena
6.1.5.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.6. Vitaros
6.1.6.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.6.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.7. Others
6.1.7.1. Market Size and Projections, 2017 - 2030 (USD Million)
6.1.7.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)

Chapter 7. Global Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)

7.1. Global Avanafil Market Share, By Route of Administration, 2017 - 2030 (USD Million)
7.1.1. Oral drugs
7.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
7.1.2. Injection
7.1.2.1. Market Size and Projections, 2017 - 2030 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)

Chapter 8. Global Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)

8.1. Global Avanafil Market Share, By Distribution Channel, 2017 - 2030 (USD Million) 
8.1.1. Offline
8.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
8.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
8.1.2. Online
8.1.2.1. Market Size and Projections, 2017 - 2030 (USD Million)
8.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)

Chapter 9. Global Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)

9.1. Global Avanafil Market Share, By Dosage, 2017 - 2030 (USD Million)
9.1.1. 25mg
9.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
9.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
9.1.2. 50mg
9.1.2.1. Market Size and Projections, 2017 - 2030 (USD Million)
9.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
9.1.3. 100mg
9.1.3.1. Market Size and Projections, 2017 - 2030 (USD Million)
9.1.3.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
9.1.4. 200mg
9.1.4.1. Market Size and Projections,2017 - 2030 (USD Million)
9.1.4.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)

Chapter 10. Global Avanafil Market Overview, By Geography, 2017 - 2030 (USD Million)

10.1. Global Avanafil Market Share, By Geography, 2017 - 2030 (USD Million)
10.1.1. Market Size and projections, by Countries, 2017 - 2030 (USD Million)
10.1.2. Market Share and CAGR Comparison, by Countries, 2021 - 2030 (%)

Chapter 11. North America Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)

11.1. North America Avanafil Market Overview, 2017 - 2030 (USD Million)
11.1.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.2. North America Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
11.1.3. North America Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
11.1.4. North America Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
11.1.5. North America Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
11.1.6. North America Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
11.1.7. North America Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)
11.1.7.1. U.S. Avanafil Market Overview, 2017 - 2030 (USD Million)
11.1.7.1.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.7.1.2. U.S. Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
11.1.7.1.3. U.S. Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
11.1.7.1.4. U.S. Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
11.1.7.1.5. U.S. Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
11.1.7.1.6. U.S. Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
11.1.7.2. Canada Avanafil Market Overview, 2017 - 2030 (USD Million)
11.1.7.2.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.7.2.2. Canada Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
11.1.7.2.3. Canada Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
11.1.7.2.4. Canada Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
11.1.7.2.5. Canada Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
11.1.7.2.6. Canada Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
11.1.7.3. Mexico Avanafil Market Overview, 2017 - 2030 (USD Million)
11.1.7.3.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.7.3.2. Mexico Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
11.1.7.3.3. Mexico Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
11.1.7.3.4. Mexico Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
11.1.7.3.5. Mexico Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
11.1.7.3.6. Mexico Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 

Chapter 12. Europe Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)

12.1. Europe Avanafil Market Overview, 2017 - 2030 (USD Million)
12.1.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.2. Europe Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.3. Europe Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.4. Europe Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.5. Europe Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.6. Europe Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
12.1.7. Europe Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)
12.1.7.1. Germany
12.1.7.1.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.7.1.2. Germany Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.7.1.3. Germany Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.7.1.4. Germany Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.7.1.5. Germany Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.7.1.6. Germany Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
12.1.7.2. France
12.1.7.2.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.7.2.2. France Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.7.2.3. France Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.7.2.4. France Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.7.2.5. France Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.7.2.6. France Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
12.1.7.3. UK
12.1.7.3.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.7.3.2. UK Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.7.3.3. UK Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.7.3.4. UK Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.7.3.5. UK Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.7.3.6. UK Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
12.1.7.4. Italy
12.1.7.4.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.7.4.2. Italy Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.7.4.3. Italy Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.7.4.4. Italy Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.7.4.5. Italy Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.7.4.6. Italy Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
12.1.7.5. Spain 
12.1.7.5.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.7.5.2. Spain Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.7.5.3. Spain Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.7.5.4. Spain Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.7.5.5. Spain Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.7.5.6. Spain Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
12.1.7.6. Rest of Europe
12.1.7.6.1. Market Size and projections, 2017– 2030
12.1.7.6.2. Rest of Europe Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
12.1.7.6.3. Rest of Europe Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
12.1.7.6.4. Rest of Europe Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
12.1.7.6.5. Rest of Europe Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
12.1.7.6.6. Rest of Europe Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 

Chapter 13. Asia Pacific Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)

13.1. Asia Pacific Avanafil Market Overview, 2017 - 2030 (USD Million)
13.1.1. Market Size and projections, 2017 - 2030 (USD Million)
13.1.2. Asia Pacific Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
13.1.3. Asia Pacific Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
13.1.4. Asia Pacific Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
13.1.5. Asia Pacific Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
13.1.6. Asia Pacific Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
13.1.7. Asia Pacific Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)
13.1.7.1. India
13.1.7.1.1. Market Size and projections, 2017 - 2030 (USD Million)
13.1.7.1.2. India Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
13.1.7.1.3. India Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
13.1.7.1.4. India Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
13.1.7.1.5. India Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
13.1.7.1.6. India Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
13.1.7.2. China
13.1.7.2.1. Market Size and projections, 2017 - 2030 (USD Million)
13.1.7.2.2. China Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
13.1.7.2.3. China Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
13.1.7.2.4. China Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
13.1.7.2.5. China Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
13.1.7.2.6. China Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
13.1.7.3. Japan
13.1.7.3.1. Market Size and projections, 2017 - 2030 (USD Million)
13.1.7.3.2. Japan Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
13.1.7.3.3. Japan Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
13.1.7.3.4. Japan Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
13.1.7.3.5. Japan Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
13.1.7.3.6. Japan Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
13.1.7.4. South Korea
13.1.7.4.1. Market Size and projections, 2017 - 2030 (USD Million)
13.1.7.4.2. South Korea Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
13.1.7.4.3. South Korea Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
13.1.7.4.4. South Korea Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
13.1.7.4.5. South Korea Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
13.1.7.4.6. South Korea Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
13.1.7.5. Rest of Asia Pacific
13.1.7.5.1. Market Size and projections, 2017 - 2030 (USD Million)
13.1.7.5.2. Rest of Asia Pacific Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
13.1.7.5.3. Rest of Asia Pacific Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
13.1.7.5.4. Rest of Asia Pacific Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
13.1.7.5.5. Rest of Asia Pacific Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
13.1.7.5.6. Rest of Asia Pacific Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 

Chapter 14. Middle East & Africa Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)

14.1. Middle East & Africa Avanafil Market Overview, 2017 - 2030 (USD Million)
14.1.1. Market Size and projections, 2017 - 2030 (USD Million)
14.1.2. Middle East & Africa Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
14.1.3. Middle East & Africa Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
14.1.4. Middle East & Africa Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
14.1.5. Middle East & Africa Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
14.1.6. Middle East & Africa Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
14.1.7. Middle East & Africa Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)
14.1.7.1. GCC
14.1.7.1.1. Market Size and projections, 2017 - 2030 (USD Million)
14.1.7.1.2. GCC Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
14.1.7.1.3. GCC Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
14.1.7.1.4. GCC Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
14.1.7.1.5. GCC Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
14.1.7.1.6. GCC Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
14.1.7.2. South Africa
14.1.7.2.1. Market Size and projections, 2017 - 2030 (USD Million)
14.1.7.2.2. South Africa Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
14.1.7.2.3. South Africa Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
14.1.7.2.4. South Africa Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
14.1.7.2.5. South Africa Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
14.1.7.2.6. South Africa Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
14.1.7.3. Rest of Middle East & Africa
14.1.7.3.1. Market Size and projections, 2017 - 2030 (USD Million)
14.1.7.3.2. Rest of Middle East & Africa Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
14.1.7.3.3. Rest of Middle East & Africa Avanafil Market Overview, BY DOSAGE, 2017 - 2030 (USD Million)
14.1.7.3.4. Rest of Middle East & Africa Avanafil Market Overview, BY ROBOT TYPE, 2017 - 2030 (USD Million)
14.1.7.3.5. Rest of Middle East & Africa Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
14.1.7.3.6. Rest of Middle East & Africa Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 

Chapter 15. South America Avanafil Market Overview, By Countries, 2017 - 2030 (USD Million)

15.1. South America Avanafil Market Overview, 2017 - 2030 (USD Million)
15.1.1. Market Size and projections, 2017 - 2030 (USD Million)
15.1.2. South America Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
15.1.3. South America Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
15.1.4. South America Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
15.1.5. South America Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
15.1.6. South America Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million)
15.1.7. South America Avanafil Market Overview, By Countries, 2017- 2030 (USD Million)
15.1.8. Brazil
15.1.8.1. Market Size and projections, 2017 - 2030 (USD Million)
15.1.8.2. Brazil Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
15.1.8.3. Brazil Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
15.1.8.3.1. Brazil Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
15.1.8.3.2. Brazil Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
15.1.8.3.3. Brazil Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
15.1.9. Argentina
15.1.9.1. Market Size and projections, 2017 - 2030 (USD Million)
15.1.9.2. Argentina Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
15.1.9.3. Argentina Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
15.1.9.3.1. Argentina Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
15.1.9.3.2. Argentina Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
15.1.9.3.3. Argentina Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 
15.1.10. Rest of South America
15.1.10.1. Market Size and projections, 2017– 2030
15.1.10.2. Rest of South America Avanafil Market Overview, By Medication Type, 2017 - 2030 (USD Million)
15.1.10.3. Rest of South America Avanafil Market Overview, By Product, 2017 - 2030 (USD Million)
15.1.10.3.1. Rest of South America Avanafil Market Overview, By Route of Administration, 2017 - 2030 (USD Million)
15.1.10.3.2. Rest of South America Avanafil Market Overview, By Distribution Channel, 2017 - 2030 (USD Million)
15.1.10.3.3. Rest of South America Avanafil Market Overview, By Dosage, 2017 - 2030 (USD Million) 

Chapter 16. Competitive Landscape

16.1. Competitive environment, 2021
16.2. Strategic framework
16.2.1. Partnership/agreement
16.2.2. Expansion
16.2.3. Mergers & Acquisitions
16.2.4. New Product development

Chapter 17. Key Vendor Analysis

17.1. Adamed
17.1.1. Company overview
17.1.2. Financial performance
17.1.3. Mice Benchmarking
17.1.4. Recent initiatives
17.1.5. SWOT analysis
17.2. Bayer AG
17.2.1. Company overview
17.2.2. Financial performance
17.2.3. Mice Benchmarking
17.2.4. Recent initiatives
17.2.5. SWOT analysis
17.3. Bristol Laboratories Ltd
17.3.1. Company overview
17.3.2. Financial performance
17.3.3. Mice Benchmarking
17.3.4. Recent initiatives
17.4. Century Pharmaceuticals Ltd
17.5. Petros Pharmaceuticals, Inc.
17.6. SK chemicals
17.7. Sun Pharmaceutical Industries Ltd
17.8. Teva Pharmaceutical Industries Ltd
17.9. Viatris Inc.
17.10. VIVUS, Inc.
17.11. Others

Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers

18.1. Avanafil Market Industrial Chain Analysis
18.2. Downstream Buyers

Chapter 19. Marketing Strategy Analysis, Distributors/Traders

19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List

Chapter 20. Market Effect Factors Analysis

20.1. Product Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Product Progress in Related Size
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change

Chapter 21. Future Outlook of the Market

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Avanafil Market, 2017-2030 (USD Million) 
4. Global Avanafil Market requirement, by country, 2017-2030, (USD Million) 
5. North America Avanafil Market, By Medication Type, 2017-2030 (USD Million)
6. North America Avanafil Market, By Product, 2017-2030 (USD Million)
7. North America Avanafil Market, By Route of Administration, 2017-2030 (USD Million)
8. North America Avanafil Market, By Distribution Channel, 2017-2030 (USD Million)
9. North America Avanafil Market, By Dosage, 2017-2030 (USD Million)
10. Europe Avanafil Market, By Medication Type, 2017-2030 (USD Million)
11. Europe Avanafil Market, By Product, 2017-2030 (USD Million)
12. Europe Avanafil Market, By Route of Administration, 2017-2030 (USD Million)
13. Europe Avanafil Market, By Distribution Channel, 2017-2030 (USD Million)
14. Europe Avanafil Market, By Dosage, 2017-2030 (USD Million)
15. Asia Pacific Avanafil Market, By Medication Type, 2017-2030 (USD Million) 
16. Asia Pacific Avanafil Market, By Product, 2017-2030 (Revenue, USD Million) 
17. Asia Pacific Avanafil Market, By Route of Administration, 2017-2030 (Revenue, USD Million) 
18. Asia Pacific Avanafil Market, By Distribution Channel, 2017-2030 (Revenue, USD Million) 
19. Asia Pacific Avanafil Market, By Dosage, 2017-2030 (Revenue, USD Million) 
20. Middle East & Africa Avanafil Market, By Medication Type, 2017-2030 (USD Million)
21. Middle East & Africa Avanafil Market, By Product, 2017-2030 (USD Million) 
22. Middle East & Africa Avanafil Market, By Route of Administration, 2017-2030 (USD Million) 
23. Middle East & Africa Avanafil Market, By Distribution Channel, 2017-2030 (USD Million) 
24. Middle East & Africa Avanafil Market, By Dosage, 2017-2030 (USD Million) 
25. South America Avanafil Market, By Medication Type, 2017-2030 (USD Million) 
26. South America Avanafil Market, By Product, 2017-2030 (USD Million) 
27. South America Avanafil Market, By Route of Administration, 2017-2030 (USD Million) 
28. South America Avanafil Market, By Distribution Channel, 2017-2030 (USD Million) 
29. South America Avanafil Market, By Dosage, 2017-2030 (USD Million) 
30. Global Avanafil Market, Company Market Share, 2021 - 2030 (%)
31. Adamed: Product Benchmarking
32. Adamed: Financial Performance
33. Bayer AG: Product Benchmarking
34. Bayer AG: Financial Performance
35. Bristol Laboratories Ltd: Product Benchmarking
36. Bristol Laboratories Ltd: Financial Performance
37. Century Pharmaceuticals Ltd: Product Benchmarking
38. Century Pharmaceuticals Ltd: Financial Performance
39. Petros Pharmaceuticals, Inc.: Product Benchmarking
40. Petros Pharmaceuticals, Inc.: Financial Performance
41. SK chemicals: Product Benchmarking
42. SK chemicals: Financial Performance
43. Sun Pharmaceutical Industries Ltd: Product Benchmarking
44. Sun Pharmaceutical Industries Ltd: Financial Performance
45. Teva Pharmaceutical Industries Ltd: Product Benchmarking
46. Teva Pharmaceutical Industries Ltd: Financial Performance
47. Viatris Inc.: Product Benchmarking
48. Viatris Inc.: Financial Performance
49. VIVUS, Inc.: Product Benchmarking
50. VIVUS, Inc.: Financial Performance

List of Figures

1. Market segmentation
2. Value chain analysis
3. Porter's Five Forces analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Avanafil Market share, By Medication Type, 2021 & 2030 (%)
10. Global Avanafil Market share, by Erectile dysfunction, By Medication Type, 2017 - 2030 (USD Million)
11. Global Avanafil Market share, by Pulmonary hypertension, By Medication Type, 2017 - 2030 (USD Million) 
12. Global Avanafil Market share, By Product, 2021 & 2030 (%)
13. Global Avanafil Market share, by Viagra, By Product, 2017 - 2030 (USD Million)
14. Global Avanafil Market share, by Cialis, By Product, 2017 - 2030 (USD Million)
15. Global Avanafil Market share, by Levitra/Staxyn, By Product 2017 - 2030 (USD Million)
16. Global Avanafil Market share, by Stendra/Spedra, By Product, 2017 - 2030 (USD Million)
17. Global Avanafil Market share, by Zydena, By Product 2017 - 2030 (USD Million)
18. Global Avanafil Market share, by Others, By Product 2017 - 2030 (USD Million)
19. Global Avanafil Market share, By Route of Administration, 2021 & 2030 (%)
20. Global Avanafil Market share, by Oral drugs, By Route of Administration, 2017 - 2030 (USD Million)
21. Global Avanafil Market share, by Injection, By Route of Administration, 2017 - 2030 (USD Million)
22. Global Avanafil Market Overview, By Distribution Channel, 2021 - 2030 (%)
23. Global Avanafil Market share, by Offline, By Distribution Channel 2017 - 2030 (USD Million)
24. Global Avanafil Market share, by Online, By Distribution Channel 2017 - 2030 (USD Million)
25. Global Avanafil Market Overview, By Dosage, 2021 - 2030 (%)
26. Global Avanafil Market share, by 25mg, By Dosage 2017 - 2030 (USD Million)
27. Global Avanafil Market share, by 50mg, By Dosage 2017 - 2030 (USD Million)
28. Global Avanafil Market share, by 100mg, By Dosage 2017 - 2030 (USD Million)
29. Global Avanafil Market share, by 200mg, By Dosage 2017 - 2030 (USD Million)
30. Global Avanafil Market share, by region, 2021 & 2030 (%)
31. Global Avanafil Market share, by region, 2017 - 2030 (USD Million)
32. North America Avanafil Market, 2017 - 2030 (USD Million)
33. North America Avanafil Market share, by Countries, 2021 & 2030 (%)
34. U.S. Avanafil Market, 2017 - 2030 (USD Million)
35. Canada Avanafil Market, 2017 - 2030 (USD Million)
36. Mexico Avanafil Market, 2017 - 2030 (USD Million)
37. Europe Avanafil Market, 2017 - 2030 (USD Million)
38. Europe Avanafil Market share, by Countries, 2021 & 2030 (%)
39. Spain Avanafil Market, 2017 - 2030 (USD Million)
40. UK Avanafil Market, 2017 - 2030 (USD Million)
41. Italy Avanafil Market, 2017 - 2030 (USD Million)
42. Germany Avanafil Market, 2017 - 2030 (USD Million)
43. France Avanafil Market, 2017 - 2030 (USD Million)
44. Rest of Europe Avanafil Market, 2017 - 2030 (USD Million)
45. Asia-Pacific Avanafil Market, 2017 - 2030 (USD Million)
46. Asia-Pacific Avanafil Market share, by Countries, 2021 & 2030 (%)
47. China Avanafil Market, 2017 - 2030 (USD Million)
48. India Avanafil Market, 2017 - 2030 (USD Million)
49. Australia Avanafil Market, 2017 - 2030 (USD Million)
50. Japan Avanafil Market, 2017 - 2030 (USD Million)
51. Rest of Asia-Pacific Avanafil Market, 2017 - 2030 (USD Million)
52. Middle East & Africa Avanafil Market, 2017 - 2030 (USD Million)
53. Middle East & Africa Avanafil Market share, by Countries, 2021 & 2030 (%)
54. GCC Avanafil Market, 2017 - 2030 (USD Million)
55. South Africa Avanafil Market, 2017 - 2030 (USD Million)
56. Rest of Middle East & Africa Avanafil Market, 2017 - 2030 (USD Million)
57. South America Avanafil Market, 2017 - 2030 (USD Million)
58. Brazil Avanafil Market, 2017 - 2030 (USD Million)
59. Argentina Avanafil Market, 2017 - 2030 (USD Million)
60. Rest of South America Avanafil Market, 2017 - 2030 (USD Million)